Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 175

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

A Pilot Study of All- trans -Retinoic Acid for the Treatment of Human Emphysema

MAO, JENNY T., GOLDIN, JONATHAN G., DERMAND, JOHN, IBRAHIM, GRACE, BROWN, MATHEW S., EMERICK, ALETHA, McNITT-GRAY, MICHAEL F., GJERTSON, DAVID W., ESTRADA, FRANCINE, TASHKIN, DONALD P., ROTH, MICHAEL D. · 2002 · American Journal of Respiratory and Critical Care Medicine

Abstract

Emphysema results from progressive destruction of alveolar septae and was considered irreversible until all-trans-retinoic acid (ATRA) was shown to reverse anatomic and physiologic signs of emphysema in a rat model. To evaluate the feasibility of ATRA as a clinical therapy, 20 patients with severe emphysema were enrolled into a randomized, double-blind, placebo-controlled pilot study. Participants included 16 male and 4 female former smokers, two with alpha(1)-antitrypsin deficiency. Patients were treated with either 3 mo of ATRA (50 mg/m(2)/d) or 3 mo of placebo, followed by a 3-mo crossover phase. Plasma drug levels were followed and outcome measures included serial pulmonary function tests, blood gases, lung compliance, computed tomography (CT) imaging, and quality of life questionnaires. In general, treatment was well tolerated and associated with only mild side effects including skin changes, transient headache, hyperlipidemia, transaminites, and musculoskeletal pains. Plasma drug levels varied considerably between subjects and decreased significantly over time in 35% of the participants. Physiologic and CT measurements did not change appreciably in response to therapy. We conclude that ATRA is well tolerated in patients with emphysema, and trials evaluating higher doses, longer treatment, or different dosing schedules are feasible.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1164/ajrccm.165.5.2106123

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 175

Metadata

Authors
MAO, J. T., GOLDIN, J. G., DERMAND, J., IBRAHIM, G., BROWN, M. S., EMERICK, A., McNITT-GRAY, M. F., GJERTSON, D. W., ESTRADA, F., TASHKIN, D. P., & ROTH, M. D.
Venue
American Journal of Respiratory and Critical Care Medicine
Published
2002-03-01
Volume
165
Issue
5
Pages
718-723
ISSN
  • 1073-449X (ISSN-L)
  • 1535-4970
OpenAlex
W2079390617
Cited by
175
References
3
FWCI
13.04
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Pilot Study of All- trans -Retinoic Acid for the Treatment of Human Emphysema. https://app.cochat.ai/papers/10.1164/ajrccm.165.5.2106123
The paper
MAO, J. T., GOLDIN, J. G., DERMAND, J., IBRAHIM, G., BROWN, M. S., EMERICK, A., McNITT-GRAY, M. F., GJERTSON, D. W., ESTRADA, F., TASHKIN, D. P., & ROTH, M. D. (2002). A Pilot Study of All- trans -Retinoic Acid for the Treatment of Human Emphysema. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/ajrccm.165.5.2106123

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.